A detailed history of Wells Fargo & Company transactions in Replimune Group, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 38,250 shares of REPL stock, worth $550,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,250
Previous 29,801 28.35%
Holding current value
$550,035
Previous $268,000 56.34%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.09 - $11.23 $68,352 - $94,882
8,449 Added 28.35%
38,250 $419,000
Q2 2024

Aug 13, 2024

BUY
$5.01 - $9.46 $17,049 - $32,192
3,403 Added 12.89%
29,801 $268,000
Q1 2024

May 10, 2024

BUY
$6.87 - $9.31 $27,541 - $37,323
4,009 Added 17.91%
26,398 $215,000
Q4 2023

Feb 09, 2024

SELL
$6.75 - $16.18 $156,384 - $374,858
-23,168 Reduced 50.85%
22,389 $188,000
Q3 2023

Nov 13, 2023

BUY
$15.96 - $22.18 $89,503 - $124,385
5,608 Added 14.04%
45,557 $779,000
Q2 2023

Aug 15, 2023

SELL
$15.65 - $24.1 $68,609 - $105,654
-4,384 Reduced 9.89%
39,949 $927,000
Q1 2023

May 12, 2023

BUY
$17.48 - $29.09 $773,559 - $1.29 Million
44,254 Added 56017.72%
44,333 $782,000
Q4 2022

Feb 13, 2023

SELL
$17.09 - $27.91 $7,485 - $12,224
-438 Reduced 84.72%
79 $2,000
Q3 2022

Nov 14, 2022

SELL
$15.6 - $21.15 $6,910 - $9,369
-443 Reduced 46.15%
517 $9,000
Q2 2022

Aug 12, 2022

SELL
$13.32 - $19.98 $21,724 - $32,587
-1,631 Reduced 62.95%
960 $17,000
Q1 2022

May 16, 2022

SELL
$15.24 - $29.75 $153,893 - $300,415
-10,098 Reduced 79.58%
2,591 $44,000
Q4 2021

Feb 14, 2022

BUY
$25.43 - $34.25 $321,969 - $433,639
12,661 Added 45217.86%
12,689 $343,000
Q2 2021

Aug 16, 2021

SELL
$28.5 - $39.37 $769,728 - $1.06 Million
-27,008 Reduced 99.9%
28 $1,000
Q1 2021

May 13, 2021

SELL
$30.22 - $45.57 $560,611 - $845,369
-18,551 Reduced 40.69%
27,036 $825,000
Q4 2020

Feb 09, 2021

BUY
$23.5 - $52.65 $747,605 - $1.67 Million
31,813 Added 230.96%
45,587 $1.74 Million
Q3 2020

Nov 05, 2020

SELL
$18.85 - $27.0 $68,934 - $98,739
-3,657 Reduced 20.98%
13,774 $317,000
Q2 2020

Aug 13, 2020

BUY
$9.76 - $25.95 $82,676 - $219,822
8,471 Added 94.54%
17,431 $433,000
Q1 2020

May 14, 2020

BUY
$8.9 - $19.08 $79,744 - $170,956
8,960 New
8,960 $89,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $709M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.